News Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Real-time Euronext Bruxelles Other stock markets 03:44:50 2026-01-19 am EST			5-day change	1st Jan Change
0.1750 ^EUR	0.00%		-5.66%	+2.94%

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE
25-09-29	Celyad Oncology : Announces Research Facility Divestiture	PU
25-09-28	An undisclosed buyer agreed to acquire Research facility?s equipment and office furniture in Mont-Saint-Guibert, Belgium of Celyad Oncology SA for ?3 million.	CI
25-09-25	Celyad Oncology SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-09-12	Celyad Oncology SA - Publication of a transparency notification received from Fortress Investment Group LLC	AQ
25-09-11	Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)	PU
25-08-26	Celyad Oncology Announces Discontinuation of R&D Activities and Workforce	CI
25-08-13	Celyad Oncology SA: Publication of a Transparency Notification Received from Fortress Investment Group LLC	PU
25-07-28	Celyad Oncology to Receive EUR1 Million Capital Injection from Shareholder	MT
25-07-28	Celyad Oncology : Announces €1 Million Private Placement	PU
25-07-27	Celyad Oncology SA announced that it expects to receive ?1 million in funding from CFIP CLYD (UK) Limited	CI
25-06-25	Celyad Oncology Begins Strategic Review Amid Limited Financial Runway	MT
25-06-24	Celyad Oncology : Announces Strategic Review	PU
25-06-24	Celyad Oncology Announces Strategic Review	CI
25-05-22	Celyad Oncology : AGM Minutes - informal translation ENG	PU
25-04-18	Celyad Oncology : Annual Report 2024 ENG	PU
25-04-18	Celyad Oncology : Report of the Statutory Auditor on the Consolidated Annual Account 2024 ENG	PU
25-04-18	Celyad Oncology : Information Note to Shareholders ENG	PU
25-04-02	Celyad Oncology : Reports Full Year 2024 Financial Results and Recent Business Highlights	PU
25-04-02	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-18	Celyad: share price soars on encouraging data
25-02-18	Celyad Oncology : announces the publication of the preclinical and clinical data of CYAD 211 providing proof of concept of its miRNA based shRNA platform	PU
25-02-18	Celyad Oncology Announces the Publication of the Preclinical and Clinical Data of CYAD-211 Providing Proof-Of-Concept of Its miRNA-Based shRNA Platform	CI
24-10-31	Celyad Oncology : Articles of Association informal version EN	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

News Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Filters